Effects of the SGLT2 Inhibition on Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats, a Model of Type 1 Diabetes Mellitus

Clinical trials have shown that sodium glucose co-transporter 2 (SGLT2) inhibitors improve clinical outcomes in diabetes mellitus (DM) patients. As most studies were performed in Type 2 DM, the cardiovascular effects of SGLT2 inhibition still require clarification in Type 1 DM. We analyzed the effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosa, Camila Moreno, Campos, Dijon Henrique Salome, Reyes, David Rafael Abreu, Damatto, Felipe Cesar, Kurosaki, Lucas Yamada, Pagan, Luana Urbano, Gomes, Mariana Janini, Corrêa, Camila Renata, Fernandes, Ana Angelica Henrique, Okoshi, Marina Politi, Okoshi, Katashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137562/
https://www.ncbi.nlm.nih.gov/pubmed/35624845
http://dx.doi.org/10.3390/antiox11050982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137562/
https://www.ncbi.nlm.nih.gov/pubmed/35624845
http://dx.doi.org/10.3390/antiox11050982

Ejemplares similares